Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs

Eli Lilly CEO Dave Ricks Talks Fighting Obesi...

Up next

Dan Arnold, SVP of National Operations at Protos Security, Talks World Cup

Dan Arnold, SVP of National Operations at Protos Security, joined Bloomberg's Carol Massar, Tim Stenovec and Vanessa Perdomo to discuss World Cup security and operations.See omnystudio.com/listener for privacy information. 

Goldman Sachs Partner John Flood Talks Selloff, Stocks Dip

Goldman Sachs Partner John Flood says to brace for near-term selloff, buy stocks dip. Flood spoked to Bloomberg's Carol Massar, Tim Stenovec and Natalia Kniazhevich.See omnystudio.com/listener for privacy information. 

Recommended Episodes

Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg Surveillance

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

Obesity Drugs Enjoy a Much-Needed Winning Streak
Bloomberg Businessweek

Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Ha ...  Show more

Chicken-Finger Billionaire Unmasked; Health Care Woes
The Credit Edge by Bloomberg Intelligence

When fast-food chain Raising Cane’s tapped the US capital market this month, it revealed a $7.6 billion fortune held by CEO Todd Graves. Strong demand for the chicken-finger maker’s bonds highlights growing investor appetite for risky debt as the US economy appears headed for a s ...  Show more

Eli Lilly CEO, Coca Cola CEO & Albertsons CEO
Mad Money w/ Jim Cramer

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...

  Show more